ERIS
682.1
2019-01-04
Eris Lifesciences Ltd
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.5447 0.5863
Current ratio 2.38 1.46
WC days 98.87 42.9
EBITDA (%) 45.2 40.65
FCF (Rs Cr.) 7 8
ROCE (%) 25.88 25.99
ROE (%) 33.87 34.11

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 0.06 0.05
Div. payout (%) 0 0
Int. Coverage 32.2 29.27
LT D/E 0.43 0.44
Solvency Ratio 0.84 0.85

Valuation STANDALONE CONSOLIDATED
Beta 0 0
Div. yield (%) 0 0
EV (Rs Cr.) 11294.3 11293.5
P/BV 12.59 12.68
P/E 37.17 37.17
PEG 1.77 1.77
P/S 14.36 12.77

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 63.13 62.69
3Y growth BV/s (%) -97 -97
Cash (Rs Cr.) 8.81 10.64
Total Debt (Rs Cr.) 376 377
Net block (Rs Cr.) 490 771

P&L metrics STANDALONE CONSOLIDATED
DPS 0 0
EPS 21.38 21.38
Net Income (Rs Cr.) 294 294
Operating profit (Rs Cr.) 316 323
No. of o/s shares 13.75 13.75
Revenue (Rs Cr.) 761 856
Total Income (Rs Cr.) 789 882

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 1716 1709
3Y growth CEPS -0.97 -0.97
CFF (Rs Cr.) 363 363
CFI (Rs Cr.) -593 -590
CFO (Rs Cr.) 236 235
FCF (Rs Cr.) 7 8
3Y growth Op. CF (%) 155 161

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) 0 0
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) 193 179
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) -96 -97
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) 253 229
1Y growth Op. CF (%) 27 18
1Q growth revenue (%) 0 0
3Y growth revenue (%) 39 57
4Q growth revenue (%) 0 0